Oncology Triumphing in trials There are certain firsts and lasts that we all remember: your first teacher, your first car, your first kiss.
Oncology Transforming autoimmune disease therapy: Post-ACR 2024 persp... The 2024 American College of Rheumatology (ACR) annual meeting spotlighted transformative advancements in cell therapies for autoimmune diseases, with chimeric antigen receptor (CAR)-T ther
Oncology Sponsored 12 Questions with Mimi Huizinga Dr Mimi Huizinga is Vice President, Oncology Medical Affairs, Lung Cancer at AstraZeneca.
Oncology Sponsored Addressing the oncological ‘other’: How predictive analysis ... In a new report, ‘Helping others: unlocking the potential of
Oncology Can CAR-T first movers keep pace in a rapidly evolving marke... The CAR-T landscape has quickly transformed from a pioneering breakthrough to a highly competitive and evolving market.
Oncology How automating flow cytometry is revolutionising cancer diag... As the incidence of cancer rises around the world, the demand for faster, more precise diagnoses is also on the rise.
News Novartis taps China's Abogen for autoimmunity TCE Novartis has added a T-cell engager developed by China's Abogen Biosciences for autoimmune disorders in a deal that could be worth over $7.5bn.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
